The present invention relates to novel heterocyclic derivatives having general formula (I) and their therapeutic use for diseases such as cancer, inflammation, pain, autoimmune diseases like Alzheimer’s or Parkinson’s disease that can be treated by modulation of certain protein kinases. Compounds of formula (I) can be used for treatment of patients who do not respond to kinase inhibition therapy that comprises currently available medications

Heterocyclic derivatives modulating the activity of certain protein kinases / M. Angiolini, F. Zuccotto, A. Bernardi, F. Airaghi.

Heterocyclic derivatives modulating the activity of certain protein kinases

A. Bernardi;F. Airaghi
2016

Abstract

The present invention relates to novel heterocyclic derivatives having general formula (I) and their therapeutic use for diseases such as cancer, inflammation, pain, autoimmune diseases like Alzheimer’s or Parkinson’s disease that can be treated by modulation of certain protein kinases. Compounds of formula (I) can be used for treatment of patients who do not respond to kinase inhibition therapy that comprises currently available medications
Eudendorn SrL
Universita' degli Studi di Milano
WO 2016/096709
MI2014A002156
23-giu-2016
Settore CHIM/06 - Chimica Organica
Heterocyclic derivatives modulating the activity of certain protein kinases / M. Angiolini, F. Zuccotto, A. Bernardi, F. Airaghi.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/413977
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact